Search results
Blockbuster cancer drug Calquence hits primary endpoint in trial for first-line mantle cell lymphoma
Endpoints News· 6 days agoAstraZeneca is working on moving its BTK inhibitor Calquence into earlier stages of mantle cell...
E-Discovery Startup Fileread Hires Former AstraZeneca Head of Legal Services Josh Kreamer as GC |...
Law.com· 5 days agoE-discovery startup Fileread announced that it has hired Josh Kreamer, who most recently served as...
Hearing set to consider penalties for pharmaceutical company over Arkansas law | Arkansas Democrat...
Arkansas Democrat-Gazette· 3 days agoA battle between the Arkansas Insurance Department and pharmaceutical manufacturers is heating up...
Fusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program...
WPRI Providence· 23 hours agoFusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines, today reported financial results ...
ANGLE teams up with AstraZeneca on a second assay
Proactive Investors· 5 days agoANGLE PLC (AIM:AGL, OTCQX:ANPCY), a leader in liquid biopsy technology, has signed a supplier agreement with AstraZeneca PLC (LSE:AZN) to develop an...
ANGLE announces second assay with AstraZeneca as it deepens relationship with pharma giant
Proactive Investors· 5 days agoANGLE PLC (AIM:AGL, OTCQX:ANPCY) chief executive Andrew Newland joins Proactive's Stephen Gunnion...
Astrazeneca plc ADR (AZN) Has A Gold Mine On Its Hands – Stocks Register
Stocks Register· 6 days agoAstrazeneca plc ADR (NASDAQ:AZN) at last check was buoying at $76.06 on Thursday, May 02, with a fall of -0.46% from its closing price on previous day. Taking a look at stock ...
McKesson (MCK) Q4 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 9 hours agoAnd in February, SCRI announced a collaboration with AstraZeneca to enhance the delivery of oncology clinical trials. Working together, the two parties...
Ionis Pharmaceuticals Inc (IONS) Q1 2024 Earnings Call Transcript Highlights: Key Developments ...
GuruFocus.com via Yahoo Finance· 2 hours agoExplore the pivotal updates from Ionis Pharmaceuticals, including new drug launches, robust pipeline progress, and strategic financial positioning in Q1 2024.
Pam Cheng
Time Magazine· 6 days agoIt’s been a challenge to introduce environmentally responsible practices in an industry built on the use of fossil fuels to drive its energy needs, from...
